Efficacy of systemic Chemotherapy on high-risk stage II and III Mucnious colon cancer. CHEMUCCA study part I
Hits: 357
- Áreas de investigación:
- Sin categoría
- Año:
- 2024
- Tipo de publicación:
- Artículo
- Palabras clave:
- Mucinous colon cancer, Systematic chemotherapy, Rectal cancer
- Autores:
-
- Trinidad-Gutiérrez, Irene
- Vázquez-Borrego, Mari C.
- Aguilera-Fernández, Eva
- Velez-Castaño, Juan E.
- Muriel-López, Carlos E.
- Rodríguez-Ortíz, Lidia
- Gómez-Orellana, Antonio Manuel
- Bérchez-Moreno, Francisco
- Hervás-Martínez, César
- Romero-Ruiz, Antonio
- Arjona-Sánchez, Álvaro
- Journal:
- European Journal of Surgical Oncology
- Volumen:
- 50
- Mes:
- November
- ISSN:
- 1532-2157
- Nota:
- JCR (2023): 3.5, Position: 31/290 (Q1), Category: SURGERY
- Abstract:
- Locally advanced colon cancer is a high-risk condition for tumour recurrence with poor survival. The current treatment is surgery followed by adjuvant chemotherapy based on fluoropyrimidines and oxaliplatin. This approach has improved the oncological outcomes on this population, however the mucinous condition has not been studied in depth and although the evidence is weak, it is thought to have a worse response to systemic chemotherapy. The CHEMUCCA study aims to answer this question.
- Comentarios:
- JCR (2023): 3.5, Position: 31/290 (Q1), Category: SURGERY
